Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer? An Open-Label, Non-Comparative, Multi-Center Clinical Trial-Reference-Cited by-同舟云学术

Is High-Dose Leuprorelin Acetate Effective and Safe in Asian Men with Prostate Cancer? An Open-Label, Non-Comparative, Multi-Center Clinical Trial

Author:

Lee Seung-Hwan¹,Lee Hyun-Moo²,Kim Sae-Woong³,Lee Eun-Sik⁴,Hong Sung-Joon⁵,Kim Choung-Soo⁶,Kang Taek-Won⁷,Chung Byung-Ha¹

Affiliation:

1. Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea.

2. Department of Urology, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea.

3. Department of Urology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

4. Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

5. Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

6. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

7. Department of Urology, Chonnam National University Hospital, Chonnam National University College of Medicine, Gwangju, Korea.

Funder

HanAll Biopharmaceutical Co., Ltd., Seoul, South Korea

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献